IPO7 and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, the bioinformatics analysis of protein-expression data allowed us to identify miR-22 and its target Importin 7 (IPO7) as possible molecular mediators of the effects observed in curcumin-treated CML cells.